Tesamorelin is a synthetic analogue of growth hormone‑releasing hormone (GHRH), positioned for researchers studying pituitary signalling and upstream control of GH secretion. Its defined sequence and activity make it a practical tool for dissecting GHRH receptor engagement and short- to medium-term signalling dynamics.

In vitro, Tesamorelin is frequently incorporated into pharmacokinetic models, receptor-binding assays, and comparative studies against other GH-axis peptides in our catalogue. The 10mg format suits exploratory work, smaller cohorts, or early-stage protocol design, while additional vial strengths are available for more extensive experimental series using the same compound.

All vials are produced to research-grade standards, with verifiable batch testing accessible on request.

Disclaimer: For research use only. Not for human or animal use or consumption.